LFWD earnings: next report 2026-08-13, real EPS beat/miss history, analyst consensus Buy, P/E -0.37. Updated 2026-07-23.
Lifeward (LFWD) Research Hub
Lifeward (LFWD) trades on NASDAQ, IL in the Healthcare (Medical - Devices) sector. As of 2026-09-11, shares last closed at 7.12 USD (-3.78%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -0.37, market cap 0.01B. This hub links to the full technical, earnings and options research available for LFWD.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Medical - Devices) |
|---|---|
| Exchange | NASDAQ, IL |
| Last close | 7.12 USD (-3.78%) |
| 52-week range | 6.75 USD – 9.61 USD |
| Trend regime | Range |
| 14-day RSI | 38.6 (Bearish) |
| Trailing P/E | -0.37 |
| Market cap | 0.01B |
| Dividend yield | 0.00% |
| Next earnings | 2026-08-13 |
Available research for LFWD
Covered Call on LFWD: how it works, illustrative setup around the real 7.12 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on LFWD: how it works, illustrative setup around the real 7.12 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on LFWD: how it works, illustrative setup around the real 7.12 USD price, max profit/loss, breakeven and when to use it. Educational.
LFWD technical analysis: range, last 7.12 USD, RSI 38.6, 52w range 6.75 USD–9.61 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is LFWD in?
Lifeward (LFWD) is classified under Healthcare (Medical - Devices), listed on NASDAQ, IL.
Is LFWD in an uptrend or downtrend?
As of 2026-09-11, LFWD is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is LFWD's trailing P/E ratio?
LFWD's trailing P/E is -0.37, with a market cap of 0.01B. See the earnings research page for full valuation detail.
When does LFWD next report earnings?
LFWD is next scheduled to report earnings on 2026-08-13, with a consensus EPS estimate of -1.38625 USD.